article thumbnail

This Week in VC with Om Malik & Paul Jozefak

Both Sides of the Table

To see the video of This Week in VC click on this link. What a pleasure that I got to spend an hour talking with both Om Malik (whom I’ve always respected his views) and Paul Jozefak , a venture capital partner at Neuhaus Partners in Germany (and formerly the head of Europe for SAP Ventures). Total raised: $5.0mm.

article thumbnail

This Week in VC with Farb Nivi, Founder of Grockit

Both Sides of the Table

This was really a fun week at TWiVC because we decided to have an entrepreneur come and talk about raising capital rather than having a VC come on. In particular I tried to do most of the “entrepreneur advice on VC” up front so that if you don’t want to watch our views on the deals you don’t have to. They sponsor TWiVC.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Calacanis: First Angels In New Angel Group

socalTECH

Calacanis--who started the group as an outgrowth of his crusade against pay-to-pitch angel groups like The Keiretsu Forum--said in his blog today that he has signed up Matt Coffin , Sky Dayton , and Bill Woodward as members of his group.

Keiretsu 133
article thumbnail

Venture Group’s Krenn Sees Improving VC Deals for SD Tech Startups

Xconomy

Call him an optimist if you must, but San Diego Venture Group president Mike Krenn says venture financings for San Diego’s early stage tech startups are on a tear. “I I haven’t seen it this good since 2007,” he says.

article thumbnail

The Challenges (& Opportunities) of Starting a Tech Company in LA

Jason Nazar

Challenge #3 – There Needs to Be More Institutional Capital in Los Angeles. There simply are NOT enough venture capital firms in the Southern California. If there were more great companies coming out of LA then it would create more demand for high quality VC firms. It’s a chicken and egg problem.

Company 111
article thumbnail

Bio Roundup: Trump News, Anthem’s Stand, Diversity by 2056 & More

Xconomy

It was a wild week in biotech and on Capitol Hill. A new study showed it may take another 40 years to achieve gender diversity in life sciences. Tensions continued to mount between drugmakers and payers over the rising costs of rare disease drugs.

News 40